Nuveen’s Stemline Therapeutics, Inc. STML Stock Holding History

Nuveen’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-147,252	Closed	-$713K	–	3439
2020 Q1	$713K	Sell	147,252 -430	-0.3%	-$2.79K	﹤0.01%	2649
2019 Q4	$1.57M	Hold	147,682	–	–	﹤0.01%	2520
2019 Q3	$1.54M	Buy	147,682 +19,223	+15%	+$251K	﹤0.01%	2519
2019 Q2	$1.97M	Buy	+128,459	New	+$1.86M	﹤0.01%	2446

Nuveen's STML Position: Q2 2020 in Review

Nuveen sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 147,252 shares — an estimated $713K sold.

Nuveen first reported a position in STML in Q2 2019 and held it in 4 quarters. The position peaked at $1.97M in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Nuveen reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Nuveen sold 147,252 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $713K.
Nuveen first reported a position in Stemline Therapeutics, Inc. in Q2 2019 and held it in 4 quarters.
Nuveen's Stemline Therapeutics, Inc. position peaked at $1.97M in Q2 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.